ENTA—There were 51K HCV patient starts in the US during 3Q17, according to GILD's 3Q17 CC. Hence, my Mavyret bogey of 10K patients in (calendar) 4Q17 ought to be doable (#msg-135663031).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.